|
|
|
05.06.25 - 14:33
|
Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index (GlobeNewswire EN)
|
|
|
HINGHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced that it has been selected for inclusion in the preliminary list of additions to the Russell Microcap® Index, as published by FTSE Russell on Friday, May 23, 2025. The newly reconstituted indexes are expected to take effect after U.S. market close on Friday, June 27, 2025, and be part of the 2025 Russell indexes reconstitution when the U.S. market opens on Monday, June 30, 2025....
|
|
|
|
|
|
|
|
|
|
|
|
|
17.01.25 - 22:03
|
Hingham Savings Reports 2024 Results (GlobeNewswire EN)
|
|
|
HINGHAM, Mass., Jan. 17, 2025 (GLOBE NEWSWIRE) -- HINGHAM INSTITUTION FOR SAVINGS (NASDAQ: HIFS), Hingham, Massachusetts announced earnings for the fourth quarter and the year ended December 31, 2024....
|
|
|
08.01.25 - 14:03
|
Microbot Medical Announces $8.6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules (GlobeNewswire EN)
|
|
|
HINGHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 3,788,550 shares of the Company's common stock at a purchase price of $2.27 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered short-term series H preferred investment options. The short-term series H preferred investment options to purchase up to 7,577,100 shares of common stock have an exercise price of $2.10 per share and are immediately exercisable following issuance for a period of two years thereafter. The closing of the registered direct offering and the concurrent private placement is expected to occur on or about January 9, 2025, subject to the satisfaction of customary closing conditions....
|
|
|
07.01.25 - 22:18
|
Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility (GlobeNewswire EN)
|
|
|
HINGHAM, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 4,000,001 shares of the Company's common stock at a purchase price of $1.75 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company issued unregistered short-term series G preferred investment options. The short-term series G preferred investment options to purchase up to 8,000,002 shares of common stock have an exercise price of $1.75 per share and are immediately exercisable following issuance for a period of two years thereafter....
|
|
|
|
|
02.01.25 - 23:54
|
XFRA : DIVIDEND/INTEREST INFORMATION - 06.01.2025 - US4333231029 (XETRA)
|
|
|
Das Instrument HS3 US4333231029 HINGHAM INSTN SVGS DL 1 EQUITY wird cum Dividende/Zinsen gehandelt am 03.01.2025 und ex Dividende/Zinsen am 06.01.2025
The instrument HS3 US4333231029 HINGHAM INSTN SVGS DL 1 EQUITY has its pre-dividend/interest day on 03.01.2025 and its ex-dividend/interest day on 06.01.2025...
|
|
|
|
|
25.11.24 - 22:03
|
Hingham Savings Declares Regular Dividend (GlobeNewswire EN)
|
|
|
HINGHAM, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- HINGHAM INSTITUTION FOR SAVINGS (NASDAQ:HIFS) (“the Bank”), Hingham, Massachusetts, announced that its Board of Directors has declared a regular quarterly cash dividend of $0.63 per share. The dividend will be paid on January 15, 2025 to stockholders of record as of January 6, 2025....
|
|
|
|
|
31.10.24 - 23:21
|
XFRA : DIVIDEND/INTEREST INFORMATION - 04.11.2024 - US4333231029 (XETRA)
|
|
|
Das Instrument HS3 US4333231029 HINGHAM INSTN SVGS DL 1 EQUITY wird cum Dividende/Zinsen gehandelt am 01.11.2024 und ex Dividende/Zinsen am 04.11.2024
The instrument HS3 US4333231029 HINGHAM INSTN SVGS DL 1 EQUITY has its pre-dividend/interest day on 01.11.2024 and its ex-dividend/interest day on 04.11.2024...
|
|
|
|
|
|
|
|
|
25.07.24 - 23:49
|
XFRA : DIVIDEND/INTEREST INFORMATION - 29.07.2024 - US4333231029 (XETRA)
|
|
|
Das Instrument HS3 US4333231029 HINGHAM INSTN SVGS DL 1 EQUITY wird cum Dividende/Zinsen gehandelt am 26.07.2024 und ex Dividende/Zinsen am 29.07.2024
The instrument HS3 US4333231029 HINGHAM INSTN SVGS DL 1 EQUITY has its pre-dividend/interest day on 26.07.2024 and its ex-dividend/interest day on 29.07.2024...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
